Real-World Treatment Patterns Among Patients Initiating Small Molecule Kinase Inhibitor Therapies for Thyroid Cancer in the United States

INTRODUCTION: Little is known about real-world use of small molecule kinase inhibitors (SMKI) for advanced thyroid cancer in the United States. This study examined prescribing patterns of SMKI agents recommended by the National Comprehensive Cancer Center (NCCN). METHODS: This retrospective study us...

Descripción completa

Detalles Bibliográficos
Autores principales: Dacosta Byfield, Stacey A., Adejoro, Oluwakayode, Copher, Ronda, Chatterjee, Debanjana, Joshi, Prashant R., Worden, Francis P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824453/
https://www.ncbi.nlm.nih.gov/pubmed/30820872
http://dx.doi.org/10.1007/s12325-019-0890-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824453/
https://www.ncbi.nlm.nih.gov/pubmed/30820872
http://dx.doi.org/10.1007/s12325-019-0890-6

Ejemplares similares